placebo and ketamine

DRUG2 trials

Sponsors

Yale University

Conditions

Cognitive DysfunctionHealthy

Phase 1

N-acetylcysteine and NMDA Antagonist Interactions

CompletedNCT00611897

Yale UniversityCognitive Dysfunction

Start: 2006-01-31End: 2011-02-28Updated: 2015-05-08

Pilot Study of ORG 25935 Modulation of Ketamine-induced Behavioral and Cognitive Effects in Healthy Male Subjects

CompletedNCT00700076

Yale UniversityHealthy

Start: 2008-01-22End: 2009-03-09Updated: 2022-03-03